Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124467318 | 12446731 | 8 | F | 20160922 | 20160608 | 20160928 | EXP | US-PFIZER INC-2016246708 | PFIZER | 75.00 | YR | M | Y | 78.50000 | KG | 20160928 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124467318 | 12446731 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | ||||||
124467318 | 12446731 | 2 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
124467318 | 12446731 | 3 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Oral | UNK, DAILY | 0 | TABLET | |||||||||
124467318 | 12446731 | 4 | C | DHEA | PRASTERONE | 1 | Oral | UNK | 0 | TABLET | |||||||||
124467318 | 12446731 | 5 | C | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG | TABLET | |||||||
124467318 | 12446731 | 6 | C | LABETALOL HCL | LABETALOL HYDROCHLORIDE | 1 | Oral | 200 MG, 2X/DAY | 0 | 200 | MG | TABLET | BID | ||||||
124467318 | 12446731 | 7 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 50 MG, DAILY | 0 | 50 | MG | TABLET | |||||||
124467318 | 12446731 | 8 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | UNK, DAILY | 0 | TABLET | |||||||||
124467318 | 12446731 | 9 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | TABLET | ||||||||||
124467318 | 12446731 | 10 | C | VELTASSA | PATIROMER | 1 | Oral | UNK | 0 | ||||||||||
124467318 | 12446731 | 11 | C | COZAAR | LOSARTAN POTASSIUM | 1 | UNK | 0 | |||||||||||
124467318 | 12446731 | 12 | C | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
124467318 | 12446731 | 13 | C | PROSCAR | FINASTERIDE | 1 | Oral | 5 MG, DAILY | 0 | 5 | MG | ||||||||
124467318 | 12446731 | 14 | C | OXYCODONE | OXYCODONE | 1 | UNK | 0 | |||||||||||
124467318 | 12446731 | 15 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
124467318 | 12446731 | 16 | C | COQ10 | UBIDECARENONE | 1 | UNK | 0 | |||||||||||
124467318 | 12446731 | 17 | C | XARELTO | RIVAROXABAN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124467318 | 12446731 | 1 | Renal cancer stage IV |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124467318 | 12446731 | OT |
124467318 | 12446731 | HO |
124467318 | 12446731 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124467318 | 12446731 | Abdominal discomfort | |
124467318 | 12446731 | Cancer pain | |
124467318 | 12446731 | Constipation | |
124467318 | 12446731 | Death | |
124467318 | 12446731 | Disease progression | |
124467318 | 12446731 | Fatigue | |
124467318 | 12446731 | Hypersomnia | |
124467318 | 12446731 | Hypoaesthesia | |
124467318 | 12446731 | Pain in extremity | |
124467318 | 12446731 | Paraesthesia | |
124467318 | 12446731 | Renal cancer stage IV | |
124467318 | 12446731 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124467318 | 12446731 | 1 | 20160427 | 0 | ||
124467318 | 12446731 | 6 | 20151217 | 0 | ||
124467318 | 12446731 | 7 | 20141121 | 0 | ||
124467318 | 12446731 | 9 | 20151230 | 0 |